Prostate Cancer

Experts Discuss PARP Inhibition in Prostate and Ovarian Cancers

February 15th 2021, 1:00pm

Article

Experts in gynecologic oncology and genitourinary oncology discuss the current state of PARP inhibitors in prostate and ovarian cancers.

Dr Ashley Ross on Genomic Testing Patients Post Prostatectomy

February 13th 2021, 2:00pm

Video

Ashley Ross, MD, PhD, urologist and associate professor at the Northwestern University Feinberg School of Medicine provides insight into genomic testing in postprostatectomy patients.

Bayer, Orion Announce Expansion of Nubeqa Development Program

February 9th 2021, 1:37pm

Article

Bayer and Orion corporation today announced the upcoming expansion of the global clinical development program for darolutamide (Nubeqa), an oral androgen receptor inhibitor for patients with prostate cancer.

MRI and Targeted Biopsy as Accurate as Current Standard for Prostate Cancer Diagnosis

February 5th 2021, 10:00pm

Article

Results from the phase 3 PRECISE trial showed that MRI with targeted biopsies matched or exceeded the accuracy of the current standard for detecting clinically significant prostate cancer.

Dr Ashley Ross on the Potential for Targeted Therapies Earlier in Prostate Cancer Treatment

February 3rd 2021, 5:50pm

Video

Ashley Ross, MD, urologist and associate professor at the Northwestern University Feinberg School of Medicine, gives insight on the potential for PARP inhibitors in earlier disease settings for prostate cancer.

Study Finds Shorter Radiation Regimen Safe, Effective for Advanced Prostate Cancer

January 30th 2021, 3:00pm

Article

Shortening a traditional 45-day course of radiation therapy to 5 days of stereotactic body radiotherapy for patients with advanced, high-risk prostate cancer is safe and effective, a study from UCLA Jonsson Comprehensive Cancer Center found.

Dr Ashley Ross on the Changing Treatment Landscape of Prostate Cancer

January 29th 2021, 8:34pm

Video

Ashley Ross, MD, PhD, urologist and associate professor at the Northwestern University Feinberg School of Medicine, discusses the increasingly dynamic treatment landscape in prostate cancer.

Mediterranean Diet Might Benefit Low-Risk Prostate Cancer Patients

January 22nd 2021, 7:05pm

Article

A recent study from the University of Texas MD Anderson Cancer Center found that men with localized prostate cancer on active surveillance might benefit from following a Mediterranean-style diet.

Prostate Cancer Tumor Size Often Underestimated by MRI, Study Finds

January 21st 2021, 10:00pm

Article

Magnetic resonance imaging (MRI) is often used in the diagnosis and management of prostate cancer, but the method frequently underestimates tumor size, a study in the Journal of Urology shows.

Dr Luis Carrascosa on Innovations in Radiation Therapy for Prostate Cancer

January 15th 2021, 9:45pm

Video

Luis Carrascosa, MD, a radiation oncologist at the Florida Cancer Specialists Ocala Cancer Center, discusses new and upcoming trends in radiation therapy for prostate cancer.